Focus
How to procure affordable
medicines and diagnostics for
hepatitis B and C
Are you an organisation running screening initiatives or
providing treatment for hepatitis B and C? By working with
the Global Procurement Fund (GPRO), you may be able to
access more affordable diagnostics tests and medicines.
What products are available in your country?
This map highlights which countries can procure medicines and diagnostics for hepatitis B and C from
GPRO.
What is the Global Procurement Fund?
GPRO is a non-profit organisation whose mission is to help organisations (CSOs, NGOs, public & private
health systems, national governments, etc.) procure affordable hepatitis medicines and diagnostics. GPRO
is a major initiative of the Center for Disease Analysis Foundation (CDAF) and focuses on low and middle-
income countries. GPRO was established in 2017 in order to expand access to quality tests and treatments
for Hepatitis B and C at pre-negotiated, discounted prices.
What are the benefits of working with GPRO?
Competitive Pricing: Using pooled procurement mechanisms, GPRO is able to pool orders across member
organisations. Higher order volumes allow GPRO to negotiate lower prices for medicines and diagnostics
than most organisations can negotiate on their own.
Assured quality: All medicines available through GRPO are authorised for use by:
• WHO pre-qualification or FDA tentative approval
• Stringent Regulatory Authority (SRA)
• Independent Expert Review Panel (ERP) when pre-qualification, FDA tentative approval, or SRA is
not available
What products are available through GPRO?
GPRO offers the following quality-assured products:
• Screening: CE-marked Rapid diagnostic tests (RDTs) for HBV and HCV
• Diagnostics: Cepheid GeneXpert Diagnostic System for viral load (NAT)
• HBV/HCV Medicines: Sofosbuvir, Daclatasvir, Tenofovir, Entecavir
For more details on what products are available in your country, click here.
How do organisations order through GPRO?
You can learn more about GPRO, including how GPRO works and how to order through GPRO here, or via
GPRO only works with manufacturers that have freedom to operate – either with a license from the
originator-companies or those with a license from the Medicines Patent Pool.
12 hep Voice June 2018
June 2018 13
hep Voice